Biomedical Systems announced that Geert Dewulf M.D. has been named the Managing Director, European Operations. Dr. Dewulf will assume the top post in the company’s European Headquarters in Brussels, Belgium from Rita Jacobs, who will be retiring from that post after 27 years with the organization. Dr. Dewulf came to Biomedical Systems from Agfa Healthcare where he served as Managing Director for Germany, Austria and Switzerland.

“We are excited to be able to bring in someone of Geert’s caliber to succeed Rita in the Brussels operation,” said Timothy R. Barrett, CEO of Biomedical Systems. “When we began the search we knew that it would be difficult to find an individual that would be able to fill Rita’s shoes. Geert’s knowledge and leadership skills blend extremely well with the corporate culture that Rita established in Brussels. The transition from Rita to Geert has been seamless.” Dr. Dewulf will officially take over the Managing Director role on 31 March 2008.

Dr. Dewulf started his career with Siemens AG, a global provider of products and services in electronics and electrical engineering, operating in the industry, energy and healthcare sectors. During his tenure with Siemens AG, he held a series of progressive assignments and responsibilities including be named Regional Sales Manager Medical Division in 1996. In 1998 he transitioned to SONY as General Manager of Business to Business where he directed sales, marketing and services through direct sales and a distribution network for Belgium and Luxemburg later as Director of Healthcare Business for Europe.

Dr. Dewulf holds a degree of Doctor in Medicine, Surgery and Obstetrics from

Katholieke Universiteit Leuven-Belgium. Additionally, Geert holds a Masters in Biomedical Techniques and a Post-graduate in Business Administration from Katholieke Universiteit Leuven. 

Biomedical Systems serves as a Corporate Member for both the ECG and Imaging Metrics Consortium Committees.

The Metrics Champion Consortium (MCC) is an open, multidisciplinary, non-profit organization. The mission of MCC is to develop, through a collaborative process, Performance Metrics within the Biotechnology and Pharmaceutical industry with the intent to jointly encourage performance improvement, effectiveness, efficiency, and appropriate levels of controls for both Sponsors and Service Providers alike.